Pan-Cancer Analysis Identified CD93 as a Valuable Biomarker for Predicting Patient Prognosis and Immunotherapy ResponseWen Tong, Yamin Zhang, Hao Wu et al.|Frontiers in Molecular Biosciences|2022Cited by 19